Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...

A multi-centre, prospective trial involving 787 subjects across Australia, Europe, and the US formed the basis for the CE ...

Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...

The phase 1b PRECISE-AD trial is currently investigating PMN310 in patients with mild cognitive impairment due to AD and in those with mild AD.

Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio ...

The test was developed in collaboration with Eli Lilly and can be used with other clinical information to rule out Alzheimer's disease as the cause of cognitive decline.

In the rapidly evolving landscape of nuclear medicine, the integration of diagnostics and therapeutics - known as ...

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.